Therapy News and Research

RSS

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Researchers evaluated the changing risk of severe COVID-19 outcomes in individuals with primary and secondary immunodeficiencies in the context of COVID-19 vaccinations.

17 Oct 2022

Study uses whole genome sequencing to trace SARS-CoV-2 transmission within Welsh hospital

In a new study, researchers used whole genome sequencing to examine the patients-to-staff, staff-to-patients, and staff-to-staff transmission of SARS-CoV-2 in hospitals in Wales.

17 Oct 2022

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Recently, authors highlighted the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in triggering the relapse of mycosis fungoides, a type of cutaneous T-cell lymphoma.

17 Oct 2022

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

In a new study, researchers evaluated the impact of the SARS-CoV-2 pandemic on the diagnosis and treatment of classical Hodgkin lymphoma (cHL) patients in Istanbul, Turkey.

17 Oct 2022

More frequent chest imaging may benefit certain colorectal cancer patients

Colorectal cancer patients with certain clinical characteristics may benefit from more frequent chest imaging to help identify and target cancer that has spread to the lungs, according to new research presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Transition in the management of COVID-19

A review of the current approaches to managing COVID-19, including diagnostic, therapeutic, and preventive measures.

16 Oct 2022

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

In silico studies assess the binding efficacy of phytoconstituents against active sites of SARS-CoV-2.

16 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

Newly identified process keeps some immune cells on their toes

Cancer cells use an unusual mechanism to migrate into new tissue and form metastases there. The same process probably also keeps some immune cells on their toes.

14 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

The utilization and provision of pediatric primary care services during the ongoing COVID-19 pandemic

The current protocol focuses on primary care pediatricians (PCPs) since they are the primary point of contact for 80% of children who need to access healthcare in many countries.

14 Oct 2022

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Patients up and down the country are set to benefit from innovative new treatments and improved delivery of health and care services following significant funding to support ground-breaking experimental medicine research and advance the UK's response to patient safety challenges.

14 Oct 2022

Widespread availability of polypills could reduce the risk of cardiovascular disease, Say cardiologists

Global health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill, say two leading cardiologists in a commentary published in The Lancet.

14 Oct 2022

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).

13 Oct 2022

Metabolite discovery offers a potential way to address metabolic conditions

"Metabolism" describes the body's chemical changes that create the necessary materials for growth and overall health. Metabolites are the substances made and used during these metabolic processes - or, as a new discovery out of Scripps Research and its drug development arm, Calibr, indicates, they could also be potent molecules for treating severe diseases.

13 Oct 2022

Therapy News and Research

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Study uses whole genome sequencing to trace SARS-CoV-2 transmission within Welsh hospital

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

More frequent chest imaging may benefit certain colorectal cancer patients

Inhalation therapeutics against COVID-19

Transition in the management of COVID-19

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

Newly identified process keeps some immune cells on their toes

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

The utilization and provision of pediatric primary care services during the ongoing COVID-19 pandemic

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Widespread availability of polypills could reduce the risk of cardiovascular disease, Say cardiologists

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Metabolite discovery offers a potential way to address metabolic conditions

Web-based app shows potential for improving communication skills of kids with developmental disorders

New findings highlight the need for strategies to mitigate widening disparities in mortality rates

Great Lakes NeuroTechnologies receives UKCA mark for KinesiaU™ motor assessment system

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivity

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News